A presentation at the ONA Summit reviewed the cancer screening guidelines from the ACS and USPSTF.
An overview of immunotherapy and the most significant adverse events nurses should monitor for in patients undergoing treatment with these novel agents.
Dr Faiman explains the disease trajectory of R/R MM and strategies for managing patient care.
Results of an online survey evaluating the experiences and preferences of patients with metastatic breast cancer were reported.
Analysis findings that demonstrated the benefit of an integrated palliative care intervention for hospitalized patients with AML were presented at the 2021 ASCO Annual Meeting.
Results of a multicenter study reveal differences in genetic testing in patients with prostate cancer who meet NCCN guidelines compared with those who do not.
Results of a study comparing weight loss success of a diet and physical activity intervention with self-directed weight loss among ALL survivors are presented at 2021 ASCO Annual Meeting.
This program is designed to support maintaining BLS skills including defibrillator use, compression and respirations, and team communication.
Researchers report on the feasibility of TFR in patients with CML-CP in updated analysis of the ENESTfreedom study.
A cost analysis shows daratumumab may be better used as a second-line treatment for transplant-ineligible patients with multiple myeloma.
